The DNA Network |
If only I’d commissioned a tango on the RET proto-oncogene… [genomeboy.com] Posted: 05 Dec 2008 04:24 PM CST Maybe I’m a sucker for methylation, but when it comes to interpretive dance as a means of explaining one’s dissertation, my vote goes to “The role of folate in epigenetic regulation of colon carcinogenesis” by Lara Park of Tufts University. You can see the rest here. |
My First Twitter Interview [ScienceRoll] Posted: 05 Dec 2008 02:22 PM CST Diariomedico.com, a Spanish medical site, kindly asked me to do an interview through Twitter. 15 short questions, 15 fast answers in the well-known 140 character-long format. It will take place on the 10th of November (Wednesday) at 12:00 EST. You can check it out if you visit my Twitter page. Feel free to follow me, join the health 2.0 discussions or just check the links I publish on Twitter. |
Radical Sharing Transforming Science [ScienceRoll] Posted: 05 Dec 2008 02:16 PM CST Cameron Neylon published another unique slideshow. The main question: Does science need transforming? |
Healthcare in Second Life: Youtube Playlist [ScienceRoll] Posted: 05 Dec 2008 02:13 PM CST I just found a playlist on Youtube that is dedicated to healthcare in Second Life, the virtual world. Numerous videos about tools for medical education and sites for patient support. An example: |
When physicists try to talk genetics... [adaptivecomplexity's blog] Posted: 05 Dec 2008 01:09 PM CST ...the result is never pretty. I made this point in a comment, but I've hoisted it up here because this issue deserves more visibility. Physics professor Steve Hsu makes this argument: |
Overview of NGS platforms [Next Generation Sequencing] Posted: 05 Dec 2008 09:10 AM CST |
CNN Shuts Down its Science Journalism Department [The Daily Transcript] Posted: 05 Dec 2008 08:54 AM CST CNN, like most other MSM outfits have been sacrificing reporters, foreign correspondents in favor of pundits (aka political operatives), fancy gizmos (verging on a reenactment of Star Wars) and fluff. The canceling of their science journalism department is just the latest decision that underscores the decay of private-sponsored journalism in this country. Is it the MSM's fault or does it say something about the whims and wishes of the general public? Sad. PZ says it best. Read the comments on this post... |
Flu Structure, Mp3s, and Magnetic Minestrone [Sciencebase Science Blog] Posted: 05 Dec 2008 07:00 AM CST You can read my latest science news updates in spectroscopynow.com: One flu over - X-ray studies have revealed details of the structure of a protein used by the avian influenza, H5N1, that allows it to hide its RNA from the infected host’s immune system. The structure could provide a new target for the development of antiviral drugs against this potentially lethal virus Minestrone and magnetic resonance - Researchers in the US and France may have overturned decades of theory in magnetic resonance studies by spotting a discrepancy in the way nuclear spins behave. Their new mathematical model of the process improves our understanding of atomic behaviour and could lead to better NMR spectra, sharper magnetic resonance images, and perhaps one day a fully portable MRI machine. Organic soil matters - Could the earth beneath our feet hold the key to climate change? According to scientists at the University of Toronto Scarborough their NMR results show that global warming is changing the molecular structure of organic matter in soil. Battery capacity is full of holes - Researchers in Korea have developed a novel material for the anode in rechargeable batteries, which they say could make them much more efficient and extend significantly the length of time between charges. And on ChemWeb for science news with a chemical element: First on the list in this week’s Alchemist, more on the new anode material, which is potentially good news for the iPod generation. In analytical research, HPLC has been used to spot dummy tequila and in medical chemistry US radiologists suggest that a dose of modified vitamin D could protect citizens from a dirty bomb attack. Next up, a new approach to addressing qubits allows for faster measurements that could take us a step closer to a quantum computer, while Yorkshire chemists are working out the best mix of starting materials to get the maximum height yield on their tasty products. Finally, this week’s award is a record breaker in the State where big is everything. |
Top Ten SNPs [Sciencebase Science Blog] Posted: 05 Dec 2008 07:00 AM CST If you ever thought genetics was only about disease, then check out the popular SNPs list on SNPedia. A SNP (pronounced “snip”) is a single nucleotide polymorphism, which in BradSpeak(TM) is basically a difference in a bit of your DNA that makes you different from the rest. Anyway, here’s the Top Five SNPs that might be described as having no obvious direct medical importance.
And, here’s the more sober list of SNPs that could have serious medical implications should you happen to discover you have one of these when you have your genome read by the likes of 23andMe.
It was a twitter discussion between SNP experts mza and attilacsordas that led me to the SNP list. |
Portuguese DNA database gets green light [My Biotech Life] Posted: 05 Dec 2008 06:18 AM CST
As I had stated a few months ago, the 3 years penalty rule is an iffy situation because there are some crimes like copyright infringement that can land you up to 3 years in jail.
Keep in mind that the penal system in Portugal is way more bland than that of the US. Here, the maximum prison sentence is 25 years (No such thing as life in prison or death penalty). The Portuguese authorities are doing their best to keep things as transparent as possible and have ensured that all will be done to guarantee the privacy of the data. Moreover, unlike the UK, criminal suspects will not be included in the DNA database and those that are acquitted will be immediately removed. Not only criminal DNA information will be stored in the database. Anyone that wishes to be included in the database can do so. This can and has been found to be helpful in identifying missing persons and unidentified corpses. Other countries like Spain and Greece have also recently began to maintain DNA databases. [Image: Wikipedia:DNA] |
Around the Blogs [Bitesize Bio] Posted: 05 Dec 2008 04:58 AM CST Three story highlights from related blogs: All Graduate Student Supervisors Take Note FDA Interested in Collaborating with Personal Genomics Companies Increased Secretion in Senescent Cells, and Chris Patil on the Campisi Lab’s New PLoS Biology Paper: Cellular Senescence, Protein Secretion, and the Aging/Cancer Paradox |
Gate Keepers for Genetic Information [The Gene Sherpa: Personalized Medicine and You] Posted: 05 Dec 2008 04:48 AM CST |
Stock Response to “How 23andMe May Be Used In Medicine” [Think Gene] Posted: 04 Dec 2008 10:56 PM CST For your own use —at your practice, institution, or otherwise. Regarding 23andMe and our genetic medical services, please note the following excepts from the 23andMe Terms of Service and the 23andMe Consent Form to which you agreed while purchasing your 23andMe test: 23andMe Terms of Service 23andMe Consent Form Thus, applying 23andMe to your health care would be a violation of the 23andMe terms of service and, as stated, it “cannot be relied upon at this point for diagnostic purposes.” We think 23andMe is a great educational tool, and we are excited about its future potential, but we cannot use the test results to provide any medical services. Further, you consented to “not change your health behaviors on the basis of [23andMe],” so for us to counsel otherwise would be unethical. Again, we would be honored to be caring for you, but any medical advice or genetic counseling services that we would provide would be exactly the same as for a patient without the 23andMe test. |
Cancer Research Blog Carnival #16 [Bayblab] Posted: 04 Dec 2008 10:47 PM CST Welcome to the 16th Edition of the Cancer Research Blog Carnival, the monthly carnival of cancer-related blogging. This month's edition has a healthy dose of cancer stem cell news, and we'll kick it off right here at the Bayblab with a post from Rob on that very topic. Rob describes a recent paper in Nature that casts some doubt on the cancer stem cell hypothesis - or at least the scarcity of these cells - though he doesn't think it's that serious a blow. Part of the evidence for the cancer stem cell hypothesis is that when human tumour cells are implanted into an immunocompromised host mouse only a small percentage of these cells are capable of reproducing a tumour. This new paper demonstrates that if the host is more immunocompromised then a larger number of cells are capable of reproducing a tumour, instead of only as low as one in a million cells to as many as one in four.Alexey at Hematopoiesis follows that up with a pair of research blogging posts also about stem cells and cancer. First off, he describes the complexity of the cell cycle and stem cell self-renewal, how disruptions in these processes can lead to hematological malignancies and how the complexity adds a layer of protection So, on one hand, downregulation of those genes promotes stem cells to exit from a quiescent state and enter into cell cycle, leading to their expansion, exhaustion and cancer development, but on the another hand, the involvement of multiple genes could protect them from it.This is followed with a post about age related changes in gene expression. Cancer is fairly well recognized as a disease of aging, but Alexey takes a closer look at specifics Now, let's get close to cancer. Bmi-1 is known as a tumor promotor, and genes that it repress - Ink4a/Arf are tumor suppressors. Hmga2 is anti-aging, but is a tumor promotor. So, aging of adult stem cell system actually protects us from cancer.Abel Pharmboy at Terra Sigillata has another piece about the link between aging and cancer. This one focuses on a recent PLoS Biology paper discussing senescence-associated secretory phenotype and how it may complicated therapies taking advantage of the senescence pathways. Cells induced to undergo senescence with DNA-damaging agents exhibit a secretory phenotype, termed the senescence-associated secretory phenotype (SASP), whereby molecules involved in inflammation and metastasis are released into the local environment. In younger individuals, thisAbel Pharmboy was also able to talk to one of the authors directly about the significance of the paper. While on the topic of unintended consequences, Philip Smith has sent us a story by dsantore at Sociology Eye. The brief piece describes the story of a New York Times editor taking testosterone suppressants as cancer treatment and found them gender blurring. Among the more notable side effects are Jennings' shrinking testicles, hot flashes, and potentially enlarged breasts. The gendered implications of these bodily changes are not lost on JenningsThe original story in the NYT is an interesting cap on the month of Movember, and a reminder of some of the lesser thought of aspects of prostate cancer. With that concludes the 16th edition of the Cancer Research Blog Carnival. The next one will appear Jan 2, but is still in need of a host. If you're sick of seeing it here at the Bayblab all the time, send us an email and we'll set you up as a future host. In the meantime, start writing posts for the next edition and submit them here. You can check out previous editions here. |
Body-Swapping with a Mannequin [adaptivecomplexity's blog] Posted: 04 Dec 2008 10:22 PM CST If you need more proof of how easy the human brain is to fool, hop over to Scientific American's 60 second science and read about how a group of mad scientists used virtual reality goggle to get subjects to 'body-swap' with a mannequin. I'm waiting for the Wii version. |
European ancestry associated with higher breast cancer risk? [Yann Klimentidis' Weblog] Posted: 04 Dec 2008 09:28 PM CST Latinas have been found to have a lower incidence of breast cancer than other ethnic groups. Indigenous Americans have the lowest incidence. This meta-review paper from a few months ago finds that ethnic disparities in breast cancer can be explained by SES, except for the lower incidence among African Americans.So what do they find in this new paper (see abstract below)? It's a case control study with a pretty large sample size (440 cases and 597 controls, matched for age) of Latinas in the SF Bay area to determine whether genetic differences between groups account for differences in breast cancer incidence. They used 106 AIMs (ancestry informative markers). Interestingly: "Breast cancer among Latinas presents a particularlyThey control for a suite of known breast cancer risk factors (including education, but unfortunately, not income). Surprisingly the cases and controls differed significantly for many of the measured risk factors. The main findings: "In unadjusted models, we found a strong association between genetic ancestry (continuous) and breast cancer risk. Higher European ancestry was associated with increased risk, with an odds ratio (OR) of 1.79 [95% confidence intervals (95% CI), 1.28–2.79; P less than 0.001] for every 25% increase in European ancestry. When known risk factors and place of birth were adjusted for (Table 2), the association with European ancestry was somewhat attenuated but remained statistically significant (OR, 1.39; 95% CI, 1.06–2.11; P = 0.013). When African ancestry was included in the adjusted model, the association with European ancestry became stronger [OR for European ancestry, 1.54 (95% CI, 1.11–2.52; P = 0.004), and OR for African ancestry, 2.05 (95% CI, 1.00–7.56; P = 0.055)]."They also looked at the association using genetic admixture and "using parent/grandparent European origin instead of genetic ancestry." "We observed a significant association between the number of European-born parents/grandparents and breast cancer risk, with higher number of European ancestors being associated with increased risk (OR, 1.21; 95% CI, 1.02–1.44; P = 0.025, adjusted model)."Although their results suggest that there may be some genetic risk factor specific to individuals with higher European ancestry, they are careful to acknowledge the possibility for residual confounders. It's too bad they didn't control for income and/or some other SES variables. Genetic Ancestry and Risk of Breast Cancer among U.S. Latinas Laura Fejerman, Esther M. John, Scott Huntsman, Kenny Beckman, Shweta Choudhry, Eliseo Perez-Stable, Esteban González Burchard and Elad Ziv Cancer Research 2008;68(23):9723–8 Abstract: U.S. Latinas have a lower incidence of breast cancer compared with non-Latina White women. This difference is partially explained by differences in the prevalence of known risk factors. Genetic factors may also contribute to this difference in incidence. Latinas are an admixed population with most of their genetic ancestry from Europeans and Indigenous Americans. We used genetic markers to estimate the ancestry of Latina breast cancer cases and controls and assessed the association with genetic ancestry, adjusting for reproductive and other risk factors. We typed a set of 106 ancestry informative markers in 440 Latina women with breast cancer and 597 Latina controls from the San Francisco Bay area and estimated genetic ancestry using a maximum likelihood method. Odds ratios (OR) and 95% confidence intervals (95% CI) for ancestry modeled as a continuous variable were estimated using logistic regression with known risk factors included as covariates. Higher European ancestry was associated with increased breast cancer risk. The OR for a 25% increase in European ancestry was 1.79 (95% CI, 1.28–2.79; P less than 0.001). When known risk factors and place of birth were adjusted for, the association with European ancestry was attenuated but remained statistically significant (OR, 1.39; 95% CI, 1.06–2.11; P = 0.013). Further work is needed to determine if the association is due to genetic differences between populations or possibly due to environmental factors not measured. |
You are subscribed to email updates from The DNA Network To stop receiving these emails, you may unsubscribe now. | Email Delivery powered by FeedBurner |
Inbox too full? Subscribe to the feed version of The DNA Network in a feed reader. | |
If you prefer to unsubscribe via postal mail, write to: The DNA Network, c/o FeedBurner, 20 W Kinzie, 9th Floor, Chicago IL USA 60610 |
No comments:
Post a Comment